Swedbank AB acquired a new position in HealthEquity, Inc. (NASDAQ:HQY – Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 437,300 shares of the company’s stock, valued at approximately $40,061,000. Swedbank AB owned approximately 0.51% of HealthEquity at the end of the most recent quarter.
A number of other large investors have also recently bought and sold shares of HQY. William Blair Investment Management LLC bought a new stake in HealthEquity in the fourth quarter worth $169,956,000. AQR Capital Management LLC boosted its holdings in HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock worth $116,016,000 after purchasing an additional 661,795 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in HealthEquity by 229,985.6% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 478,578 shares of the company’s stock worth $43,843,000 after purchasing an additional 478,370 shares in the last quarter. Westfield Capital Management Co. LP boosted its holdings in HealthEquity by 35.7% in the third quarter. Westfield Capital Management Co. LP now owns 1,716,658 shares of the company’s stock worth $162,688,000 after purchasing an additional 451,450 shares in the last quarter. Finally, Woodline Partners LP bought a new stake in HealthEquity in the third quarter worth $26,193,000. 99.55% of the stock is currently owned by institutional investors.
HealthEquity Price Performance
HQY stock opened at $88.11 on Monday. The company has a debt-to-equity ratio of 0.45, a current ratio of 3.27 and a quick ratio of 3.27. HealthEquity, Inc. has a 52-week low of $72.76 and a 52-week high of $116.65. The company has a 50-day moving average of $82.48 and a two-hundred day moving average of $86.92. The stock has a market capitalization of $7.39 billion, a price-to-earnings ratio of 35.82, a price-to-earnings-growth ratio of 1.60 and a beta of 0.19.
Wall Street Analysts Forecast Growth
A number of equities research analysts recently issued reports on the stock. Deutsche Bank Aktiengesellschaft upped their price objective on shares of HealthEquity from $120.00 to $128.00 and gave the stock a “buy” rating in a report on Thursday, March 19th. Barclays decreased their price objective on shares of HealthEquity from $118.00 to $110.00 and set an “overweight” rating for the company in a report on Wednesday, February 18th. UBS Group set a $110.00 price objective on shares of HealthEquity in a report on Tuesday, February 17th. Raymond James Financial set a $100.00 price objective on shares of HealthEquity in a report on Tuesday, February 17th. Finally, Barrington Research reiterated an “outperform” rating and issued a $110.00 price objective on shares of HealthEquity in a report on Friday. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $111.79.
View Our Latest Stock Analysis on HealthEquity
HealthEquity Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Featured Articles
- Five stocks we like better than HealthEquity
- The Smart Glasses Gold Rush Is Leaving Old-School Eyewear Behind
- 3 Rare Earth Stocks That Win No Matter What China Does Next
- Amylyx Stock: Why the Full Pipeline Story Matters
- Palantir and Dell Build an AI OS for the Paranoid
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
